Mary Wilson
Well-known member
Published: January 17, 2024
DOI:https://doi.org/10.1016/S2666-5247(23)00405-6
Heng Li, Shengkai Li, Huajiang Yang, Zhengrong Chen, Zhemin Zhou
In The Lancet Microbe, Patrick M Meyer Sauteur and colleagues1 reported about a delayed re-emergence of Mycoplasma pneumoniae after the COVID-19 pan- demic restrictions. According to initial study findings, China is currently facing a concurrent outbreak of paediatric respiratory diseases, particularly the macrolide-resistant M pneumoniae(MRMP)outbreak.2 Onthebasisofmore than 30000 PCR tests and bronchos- copy findings (appendix p 3) in a paediatric hospital in east China from 2017 to 2023, we found a pronounced re-emergence of M pneumoniae, with up to 50% positive cases noted since July, 2023 (appendix p 2), compared with a lower incidence of positive cases ranging from 10% to 20% during the COVID-19 period (2020–22). ...
https://www.thelancet.com/action/showPdf?pii=S2666-5247(23)00405-6
DOI:https://doi.org/10.1016/S2666-5247(23)00405-6
Heng Li, Shengkai Li, Huajiang Yang, Zhengrong Chen, Zhemin Zhou
In The Lancet Microbe, Patrick M Meyer Sauteur and colleagues1 reported about a delayed re-emergence of Mycoplasma pneumoniae after the COVID-19 pan- demic restrictions. According to initial study findings, China is currently facing a concurrent outbreak of paediatric respiratory diseases, particularly the macrolide-resistant M pneumoniae(MRMP)outbreak.2 Onthebasisofmore than 30000 PCR tests and bronchos- copy findings (appendix p 3) in a paediatric hospital in east China from 2017 to 2023, we found a pronounced re-emergence of M pneumoniae, with up to 50% positive cases noted since July, 2023 (appendix p 2), compared with a lower incidence of positive cases ranging from 10% to 20% during the COVID-19 period (2020–22). ...
https://www.thelancet.com/action/showPdf?pii=S2666-5247(23)00405-6